Xocova’s Uptake in Japan in Line with Expectations: Shionogi CEO

May 11, 2023
Shionogi Chairman and CEO Isao Teshirogi Shionogi Chairman and CEO Isao Teshirogi said on May 10 that the penetration of the company’s COVID-19 pill Xocova (ensitrelvir) has been “in line with expectations so far.” With patient copay possibly starting from...read more